Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Monday's session: top gainers and losers ↗
March 09, 2026
Wondering what's happening in today's pre-market session? ↗
March 09, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
February 04, 2026
Olema Insider Sells $8 Million in Shares After 300% Stock Surge ↗
January 09, 2026
In today's session, these stocks are experiencing unusual volume. ↗
November 20, 2025
Keep an eye on the top gainers and losers in Thursday's session. ↗
November 20, 2025
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 20, 2025
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million ↗
November 20, 2025
Frequently Asked QuestionsIs Olema Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Olema Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Olema Pharmaceuticals, Inc. - Common Stock trade on?
Olema Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock is OLMA on the Nasdaq Stock Market
What is the current price of Olema Pharmaceuticals, Inc. - Common Stock?
The current price of Olema Pharmaceuticals, Inc. - Common Stock is 15.61
When was Olema Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Olema Pharmaceuticals, Inc. - Common Stock was at 03/11/26 04:00 PM ET
What is the market capitalization of Olema Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Olema Pharmaceuticals, Inc. - Common Stock is 854.96M
How many shares of Olema Pharmaceuticals, Inc. - Common Stock are outstanding?
Olema Pharmaceuticals, Inc. - Common Stock has 855M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|